Rolland-Yves Mauvernay
Presidente en Debiopharm Innovation Fund /Management/ .
Cargos activos de Rolland-Yves Mauvernay
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Debiopharm Innovation Fund /Management/
Debiopharm Innovation Fund /Management/ Investment ManagersFinance Debiopharm Innovation Fund SA develops, manufactures, and markets diagnostic systems. It seeks to invest in the biotechnology, diagnostics, and pharmaceutical industries with a focus on biomarker development, and large molecule capabilities. The firm mission is to invest in innovative diagnostic companies developing platforms and content to complement in-house diagnostic activities, give insight into cutting-edge diagnostics and facilitate access to new technologies. The company was founded in 1979 and is headquartered in Fribourg, Switzerland. | Presidente | - | - |
Historial de carrera de Rolland-Yves Mauvernay
Antiguos cargos conocidos de Rolland-Yves Mauvernay.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Fundador | 01/01/1979 | - |
Presidente | 01/01/1979 | - |
Formación de Rolland-Yves Mauvernay.
University of Strasbourg | Doctorate Degree |
Estadísticas
Internacional
Suiza | 3 |
Francia | 2 |
Operativa
Founder | 1 |
President | 1 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 2 |
Consumer Services | 2 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Health Technology |
Debiopharm Innovation Fund /Management/
Debiopharm Innovation Fund /Management/ Investment ManagersFinance Debiopharm Innovation Fund SA develops, manufactures, and markets diagnostic systems. It seeks to invest in the biotechnology, diagnostics, and pharmaceutical industries with a focus on biomarker development, and large molecule capabilities. The firm mission is to invest in innovative diagnostic companies developing platforms and content to complement in-house diagnostic activities, give insight into cutting-edge diagnostics and facilitate access to new technologies. The company was founded in 1979 and is headquartered in Fribourg, Switzerland. | Finance |